BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37773074)

  • 21. Clinical, Morphological and Molecular Features of Spitz tumors.
    Donati M; Mansour B; Hagstrom M; Gerami P; Kazakov DV
    Cesk Patol; 2024; 60(1):35-48. PubMed ID: 38697826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activating HRAS mutation in agminated Spitz nevi arising in a nevus spilus.
    Sarin KY; Sun BK; Bangs CD; Cherry A; Swetter SM; Kim J; Khavari PA
    JAMA Dermatol; 2013 Sep; 149(9):1077-81. PubMed ID: 23884457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spitz melanocytic tumours - a review.
    Yeh I; Busam KJ
    Histopathology; 2022 Jan; 80(1):122-134. PubMed ID: 34958498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cdc7 expression in melanomas, Spitz tumors and melanocytic nevi.
    Clarke LE; Fountaine TJ; Hennessy J; Bruggeman RD; Clarke JT; Mauger DT; Helm KF
    J Cutan Pathol; 2009 Apr; 36(4):433-8. PubMed ID: 19278428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Digging into uncertainty: a case report on Spitz lesions.
    Merzel Šabović EK; Jejinić D; Pagon A; Jugovar N; Hosta V
    Acta Dermatovenerol Alp Pannonica Adriat; 2024 Mar; 33(1):49-52. PubMed ID: 38214489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BRAF Mutated and Morphologically Spitzoid Tumors, a Subgroup of Melanocytic Neoplasms Difficult to Distinguish From True Spitz Neoplasms.
    Gerami P; Chen A; Sharma N; Patel P; Hagstrom M; Kancherla P; Geraminejad T; Olivares S; Biswas A; Bosenberg M; Busam KJ; de La Fouchardière A; Duncan LM; Elder DE; Ko J; Landman G; Lazar AJ; Lowe L; Massi D; Mihic-Probst D; Parker DC; Scolyer RA; Shea CR; Zembowicz A; Yun SJ; Blokx WAM; Barnhill RL
    Am J Surg Pathol; 2024 May; 48(5):538-545. PubMed ID: 38525831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical Spitz Tumors: A Diagnostic Challenge.
    Harms KL; Lowe L; Fullen DR; Harms PW
    Arch Pathol Lab Med; 2015 Oct; 139(10):1263-70. PubMed ID: 26414472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amplification of Mutant NRAS in Melanocytic Tumors With Features of Spitz Tumors.
    Cloutier JM; Wang M; Vemula SS; Mirza S; Weier J; Aquino JD; McCalmont TH; LeBoit PE; Bastian BC; Yeh I
    Mod Pathol; 2024 May; 37(5):100469. PubMed ID: 38467248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and pathologic findings of Spitz nevi and atypical Spitz tumors with ALK fusions.
    Busam KJ; Kutzner H; Cerroni L; Wiesner T
    Am J Surg Pathol; 2014 Jul; 38(7):925-33. PubMed ID: 24698967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRAF, NRAS and HRAS mutations in spitzoid tumours and their possible pathogenetic significance.
    Da Forno PD; Pringle JH; Fletcher A; Bamford M; Su L; Potter L; Saldanha G
    Br J Dermatol; 2009 Aug; 161(2):364-72. PubMed ID: 19438459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nevoid melanoma: a clinicopathological study of seven cases of malignant melanoma mimicking spindle and epithelioid cell nevus and verrucous dermal nevus.
    Wong TY; Suster S; Duncan LM; Mihm MC
    Hum Pathol; 1995 Feb; 26(2):171-9. PubMed ID: 7860047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HRAS-mutated Spitz tumors: A subtype of Spitz tumors with distinct features.
    van Engen-van Grunsven AC; van Dijk MC; Ruiter DJ; Klaasen A; Mooi WJ; Blokx WA
    Am J Surg Pathol; 2010 Oct; 34(10):1436-41. PubMed ID: 20871217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
    Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
    Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S100A6 protein expression is different in Spitz nevi and melanomas.
    Ribé A; McNutt NS
    Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of p15 in a spectrum of spitzoid melanocytic neoplasms.
    Ma SA; O'Day CP; Dentchev T; Takeshita J; Ridky TW; Seykora JT; Chu EY
    J Cutan Pathol; 2019 May; 46(5):310-316. PubMed ID: 30666677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TERT Promoter Mutational Analysis as an Ancillary Diagnostic Tool for Diagnostically Challenging Melanocytic Neoplasms.
    Boutko A; Asadbeigi S; Roth A; Lampley N; Olivares S; Dittmann D; Dittmann D; Jennings L; Gerami P
    Am J Dermatopathol; 2023 May; 45(5):289-299. PubMed ID: 36898007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spitz Nevus and Other Spitzoid Tumors in Children. Part 2: Cytogenetic and Molecular Features. Prognosis and Treatment.
    Sainz-Gaspar L; Sánchez-Bernal J; Noguera-Morel L; Hernández-Martín A; Colmenero I; Torrelo A
    Actas Dermosifiliogr (Engl Ed); 2020 Jan; 111(1):20-25. PubMed ID: 31739993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spitz nevus, Spitz tumor, and spitzoid melanoma: a comprehensive clinicopathologic overview.
    Ferrara G; Gianotti R; Cavicchini S; Salviato T; Zalaudek I; Argenziano G
    Dermatol Clin; 2013 Oct; 31(4):589-98, viii. PubMed ID: 24075547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
    Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
    Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immunohistochemical profile of Spitz nevi and conventional (non-Spitzoid) melanomas: a baseline study.
    Garrido-Ruiz MC; Requena L; Ortiz P; Pérez-Gómez B; Alonso SR; Peralto JL
    Mod Pathol; 2010 Sep; 23(9):1215-24. PubMed ID: 20543820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.